BioAge Labs
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAge Labs and other ETFs, options, and stocks.About BIOA
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs.
CEOKristen Fortney
CEOKristen Fortney
Employees64
Employees64
HeadquartersEmeryville, California
HeadquartersEmeryville, California
Founded2015
Founded2015
Employees64
Employees64
BIOA Key Statistics
Market cap454.33M
Market cap454.33M
Price-Earnings ratio-6.00
Price-Earnings ratio-6.00
Dividend yield—
Dividend yield—
Average volume425.01K
Average volume425.01K
High today$12.85
High today$12.85
Low today$12.04
Low today$12.04
Open price$12.13
Open price$12.13
Volume412.04K
Volume412.04K
52 Week high$12.85
52 Week high$12.85
52 Week low$2.88
52 Week low$2.88
Stock Snapshot
With a market cap of 454.33M, BioAge Labs(BIOA) trades at $12.85. The stock has a price-to-earnings ratio of -6.00.
During the trading session on 2025-12-11, BioAge Labs(BIOA) shares reached a daily high of $12.85 and a low of $12.04. At a current price of $12.85, the stock is +6.7% higher than the low and still 0.0% under the high.
Trading volume for BioAge Labs(BIOA) stock has reached 412.04K, versus its average volume of 425.01K.
The stock's 52-week range extends from a low of $2.88 to a high of $12.85.
The stock's 52-week range extends from a low of $2.88 to a high of $12.85.
People also own
Based on the portfolios of people who own BIOA. This list is generated using Robinhood data, and it’s not a recommendation.